BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 21572997)

  • 1. DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs.
    So AY; Jung JW; Lee S; Kim HS; Kang KS
    PLoS One; 2011 May; 6(5):e19503. PubMed ID: 21572997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human epidermal stem cell proliferation and senescence requires polycomb- dependent and -independent functions of Cbx4.
    Luis NM; Morey L; Mejetta S; Pascual G; Janich P; Kuebler B; Cozutto L; Roma G; Nascimento E; Frye M; Di Croce L; Benitah SA
    Cell Stem Cell; 2011 Sep; 9(3):233-46. PubMed ID: 21885019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
    Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
    Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
    Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
    Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
    Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
    Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist-1 induces Ezh2 recruitment regulating histone methylation along the Ink4A/Arf locus in mesenchymal stem cells.
    Cakouros D; Isenmann S; Cooper L; Zannettino A; Anderson P; Glackin C; Gronthos S
    Mol Cell Biol; 2012 Apr; 32(8):1433-41. PubMed ID: 22290439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.
    Bracken AP; Kleine-Kohlbrecher D; Dietrich N; Pasini D; Gargiulo G; Beekman C; Theilgaard-Mönch K; Minucci S; Porse BT; Marine JC; Hansen KH; Helin K
    Genes Dev; 2007 Mar; 21(5):525-30. PubMed ID: 17344414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis.
    Sasaki M; Yamaguchi J; Itatsu K; Ikeda H; Nakanuma Y
    J Pathol; 2008 Jun; 215(2):175-83. PubMed ID: 18393368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMI1 sustains human glioblastoma multiforme stem cell renewal.
    Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
    J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
    Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
    Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Polycomb group protein EZH2 directly controls DNA methylation.
    Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F
    Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate matter-induced senescence of skin keratinocytes involves oxidative stress-dependent epigenetic modifications.
    Ryu YS; Kang KA; Piao MJ; Ahn MJ; Yi JM; Bossis G; Hyun YM; Park CO; Hyun JW
    Exp Mol Med; 2019 Sep; 51(9):1-14. PubMed ID: 31551408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence.
    Agherbi H; Gaussmann-Wenger A; Verthuy C; Chasson L; Serrano M; Djabali M
    PLoS One; 2009 May; 4(5):e5622. PubMed ID: 19462008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells.
    Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K
    Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone H3 modifications associated with differentiation and long-term culture of mesenchymal adipose stem cells.
    Noer A; Lindeman LC; Collas P
    Stem Cells Dev; 2009 Jun; 18(5):725-36. PubMed ID: 18771397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.
    Kotake Y; Cao R; Viatour P; Sage J; Zhang Y; Xiong Y
    Genes Dev; 2007 Jan; 21(1):49-54. PubMed ID: 17210787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing.
    Wu X; Gong Y; Yue J; Qiang B; Yuan J; Peng X
    Nucleic Acids Res; 2008 Jun; 36(11):3590-9. PubMed ID: 18460542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.
    Saidj D; Cros MP; Hernandez-Vargas H; Guarino F; Sylla BS; Tommasino M; Accardi R
    J Virol; 2013 Nov; 87(22):12139-50. PubMed ID: 24006445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycomb repressor complex-2 is a novel target for mesothelioma therapy.
    Kemp CD; Rao M; Xi S; Inchauste S; Mani H; Fetsch P; Filie A; Zhang M; Hong JA; Walker RL; Zhu YJ; Ripley RT; Mathur A; Liu F; Yang M; Meltzer PA; Marquez VE; De Rienzo A; Bueno R; Schrump DS
    Clin Cancer Res; 2012 Jan; 18(1):77-90. PubMed ID: 22028491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.